Therapeutic Asset Ratings

3,272 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Gsk-2636771 Melanoma	National Cancer Institute (NCI)	P2	CC (45)
Ipatasertib Melanoma	National Cancer Institute (NCI)	P2	CC (45)
Larotrectinib Melanoma	National Cancer Institute (NCI)	P2	CC (45)
mk-2206 Triple-Negative Breast Carcinoma	National Cancer Institute (NCI)	P2	CC (45)
Nogapendekin Alfa Inbakicept Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CC (45)
Omega-3-Acid Ethyl Esters Breast Carcinoma	National Cancer Institute (NCI)	P2	CC (45)
Osimertinib Melanoma	National Cancer Institute (NCI)	P2	CC (45)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493 Melanoma	National Cancer Institute (NCI)	P2	CC (45)
Pertuzumab Melanoma	National Cancer Institute (NCI)	P2	CC (45)
Sapanisertib Melanoma	National Cancer Institute (NCI)	P2	CC (45)
Simvastatin Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CC (45)
Taselisib Colorectal Carcinoma	National Cancer Institute (NCI)	P2	CC (45)
Taselisib Glioma	National Cancer Institute (NCI)	P2	CC (45)
Triadeno Vaccine Neoplasm	National Cancer Institute (NCI)	P2	CC (45)
Ulixertinib Hepatocellular Carcinoma	National Cancer Institute (NCI)	P2	CC (45)
Vismodegib Melanoma	National Cancer Institute (NCI)	P2	CC (45)
Young Til Colorectal Cancer	National Cancer Institute (NCI)	P2	CC (45)
C-Car066 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	National Cancer Institute (NCI)	P1	CC (45)
Anti-Kras G12V Mtcr Pbl Digestive System Cancer	National Cancer Institute (NCI)	P1/2	CC (45)
Autologous Hucd19 Car T Cells B-Cell Chronic Lymphocytic Leukemia	National Cancer Institute (NCI)	P1/2	CC (45)
Avelumab Cholangiocarcinoma	National Cancer Institute (NCI)	P1/2	CC (45)
Avelumab Gallbladder Carcinoma	National Cancer Institute (NCI)	P1/2	CC (45)
Avelumab Gallbladder Cancer	National Cancer Institute (NCI)	P1/2	CC (45)
Bet Bromodomain Inhibitor Zen-3694 Malignant Pancreatic Neoplasm	National Cancer Institute (NCI)	P1/2	CC (45)
Cis-Diamminedichloroplatinum Ii Refractory Malignant Neoplasm	National Cancer Institute (NCI)	P1/2	CC (45)

Showing 2576 to 2600 of 3,272 assets

PreviousPage 104 of 131Next